ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 120,30
0,35%
Dow Jones
39 671,04
-0,51%
DAX
18 731,80
0,27%
Brent Oil
82,255
0,89%
Bitcoin
69 956,70
1,24%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. AgeX Therapeutics Inc (AGE)

  7. AgeX Therapeutics Inc (AGE) Actualités

AGE

AgeX Therapeutics (AGE)

AgeX Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:AGE
DateHeureSourceTitreSymboleSociété
22/03/202422h27GlobeNewswire Inc.AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
07/03/202422h49Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsAMEX:AGEAgeX Therapeutics Inc
07/03/202422h47Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
07/03/202413h47Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
14/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AGEAgeX Therapeutics Inc
18/01/202423h29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:AGEAgeX Therapeutics Inc
16/01/202415h11Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]AMEX:AGEAgeX Therapeutics Inc
15/11/202315h38Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
14/11/202322h05Business WireAgeX Therapeutics Reports Third Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
07/11/202322h06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AGEAgeX Therapeutics Inc
22/09/202322h05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:AGEAgeX Therapeutics Inc
30/08/202313h00Business WireSerina Therapeutics and AgeX Therapeutics Enter into Merger AgreementAMEX:AGEAgeX Therapeutics Inc
14/08/202322h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AGEAgeX Therapeutics Inc
14/08/202322h05Business WireAgeX Therapeutics Reports Second Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
25/07/202300h28Business WireAgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred StockAMEX:AGEAgeX Therapeutics Inc
21/07/202323h32Business WireAgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred StockAMEX:AGEAgeX Therapeutics Inc
08/06/202322h06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AGEAgeX Therapeutics Inc
23/05/202322h05Business WireAgeX Therapeutics Announces Appeal of NYSE American DeterminationAMEX:AGEAgeX Therapeutics Inc
18/05/202322h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:AGEAgeX Therapeutics Inc
12/05/202322h05Business WireAgeX Therapeutics Reports First Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
26/04/202322h05Business WireAgeX Therapeutics Receives Stock Exchange Deficiency LetterAMEX:AGEAgeX Therapeutics Inc
31/03/202322h05Business WireAgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
22/03/202321h20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:AGEAgeX Therapeutics Inc
22/03/202321h17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:AGEAgeX Therapeutics Inc
06/02/202322h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:AGEAgeX Therapeutics Inc
25/11/202221h41Business WireAgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing RequirementsAMEX:AGEAgeX Therapeutics Inc
10/11/202222h21Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AGEAgeX Therapeutics Inc
10/11/202222h05Business WireAgeX Therapeutics Reports Third Quarter 2022 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
02/11/202221h48Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:AGEAgeX Therapeutics Inc
05/10/202222h07Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)AMEX:AGEAgeX Therapeutics Inc
 Showing the most relevant articles for your search:AMEX:AGE

Dernières Valeurs Consultées

TSXV
KCC
Kincora Copper
NASDAQ
CISS
C3is
CREX
DOGEUSDT
Dogecoin
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés